Pilot Study of Cystochon® (Cranberry Extract, Chondroitin Sulfate, and Hyaluronic Acid Complex) in Interstitial Cystitis/Bladder Pain Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study examined whether Cystochon® (cranberry extract, chondroitin sulfate, and hyaluronic acid complex) effectively improves the symptoms and problems of interstitial cystitis/bladder pain syndrome (IC/BPS) patients. Materials and Methods: From December 2021 to May 2022, the medical records of IC/BPS patients who visited St. Vincent’s Hospital, Kyung Hee University Medical Center, or Gachon University Gil Medical Center were collected. For the treatment of IC/BPS, the patients were given pentosan polysulfate (PPS) for 12 weeks, with Cystochon® then added and maintained for an additional eight weeks. The OʼLeary–Sant symptom and problem index (Interstitial Cystitis Symptom Index [ICSI], Interstitial Cystitis Problem Index [ICPI]) was used to measure the treatment response. Results: After 12 weeks of PPS treatment, ICSI and ICPI improved in all patients. After adding Cystochon® for eight weeks, the ICSI and ICPI indicators improved further. In the ICSI category, significant improvement in symptoms was confirmed in the total ICSI score, particularly in the Q4 (pain-related) questionnaire after adding Cystochon®. In the ICPI category, significant problem improvement was confirmed in the total ICPI score, particularly in the Q1 (frequent urination) and Q4 (pain-related) questionnaires. Although not statistically significant, the remaining indicators generally tended to improve. Conclusions: The orally administered combination of cranberry extract, chondroitin sulfate, and hyaluronic acid (Cystochon®) may have a clinically positive effect in patients with IC/BPS. Better clinical improvement can be expected when it is added to the PPS treatment, especially in the category of bladder pain.
Abstract
Purpose: This study examined whether Cystochon® (cranberry extract, chondroitin sulfate, and hyaluronic acid complex) effectively improves the symptoms and problems of interstitial cystitis/bladder pain syndrome (IC/BPS) patients. Materials and Methods: From December 2021 to May 2022, the medical records of IC/BPS patients who visited St. Vincent’s Hospital, Kyung Hee University Medical Center, or Gachon University Gil Medical Center were collected. For the treatment of IC/BPS, the patients were given pentosan polysulfate (PPS) for 12 weeks, with Cystochon® then added and maintained for an additional eight weeks. The OʼLeary–Sant symptom and problem index (Interstitial Cystitis Symptom Index [ICSI], Interstitial Cystitis Problem Index [ICPI]) was used to measure the treatment response. Results: After 12 weeks of PPS treatment, ICSI and ICPI improved in all patients. After adding Cystochon® for eight weeks, the ICSI and ICPI indicators improved further. In the ICSI category, significant improvement in symptoms was confirmed in the total ICSI score, particularly in the Q4 (pain-related) questionnaire after adding Cystochon®. In the ICPI category, significant problem improvement was confirmed in the total ICPI score, particularly in the Q1 (frequent urination) and Q4 (pain-related) questionnaires. Although not statistically significant, the remaining indicators generally tended to improve. Conclusions: The orally administered combination of cranberry extract, chondroitin sulfate, and hyaluronic acid (Cystochon®) may have a clinically positive effect in patients with IC/BPS. Better clinical improvement can be expected when it is added to the PPS treatment, especially in the category of bladder pain.
참고문헌 (16)
- Lin KB, "Lifestyle and behavioral modifications made by patients with interstitial cystitis", Sci Rep, 11, pp.3055~ (2021)
- Tornero JI, "Long-term experience with sodium chondroitin sulfate in patients with painful bladder syndrome", Actas Urol Esp, 37, pp.523~526 (2013)
- Giberti C, "Combined intravesical sodium hyaluronate", chondroitin sulfate therapy for interstitial cystitis, Ther Adv Urol, pp.2013, 5[DOI]
- Porru D, "Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome", interstitial cystitis, 2012, pp.23, 1193~1199
- O'Leary MP, "The interstitial cystitis symptom index and problem index", Urology, 49(5A Suppl), pp.58~63 (1997)
- Micali S, "Cranberry and recurrent cystitis : more than marketing", Crit Rev Food Sci Nutr, 54, pp.1063~1075 (2014)
- Naber K, "Colleagues' tips against recurrent cystitis. Cranberry juice instead of antibiotics", MMW Fortschr Med, 145, pp.12~13 (2003)
- Bruyère F, "A multicenter, randomized, placebo-controlled study evaluating the efficacy of a combination of propolis and cranberry(Vaccinium macrocarpon)(DUAB®)in preventing low urinary tract infection recurrence in women complaining of recurrent cystitis", Urol Int, 103, pp.41~48 (2019)
- González de Llano D, "Cranberry polyphenols and prevention against urinary tract infections : relevant considerations", Molecules, 25, pp.3523~ (2020)
- Caretto M, "Preventing urinary tract infections after menopause without antibiotics", Maturitas, 99, pp.43~46 (2017)
- Ciani O, "Intravesical administration of combined hyaluronic acid(HA)and chondroitin sulfate(CS)for the treatment of female recurrent urinary tract infections : a European multicentre nested case-control study", BMJ Open, 6, pp.e009669~ (2016)
- Simental-Mendía M, "Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis : a systematic review and meta-analysis of randomized placebo-controlled trials", Rheumatol Int, 38, pp.1413~1428 (2018)
- Stellavato A, "Hyaluronic acid and chondroitin sulfate, alone or in combination, efficiently counteract induced bladder cell damage and inflammation", PLoS One, 14, pp.e0218475~ (2019)
- Torella M, "Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women", Eur J Obstet Gynecol Reprod Biol, 207, pp.125~128 (2016)
- Theoharides TC, "A pilot open label study of Cystoprotek in interstitial cystitis", Int J Immunopathol Pharmacol, 18, pp.183~188 (2005)
- Theoharides TC, "Treatment of refractory interstitial cystitis", painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement, 2008, pp.15, 4410~4414